Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Annals of Indian Academy of Neurology|June 14, 2016
Sporadic and familial myoclonic dystonia: Report of three cases and review of literatureKalyan B Bhattacharyya, Arijit Roy, Atanu Biswas, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 23, 2007
Radiosynthesis of 2'-deoxy-2'-[18F]-fluoro-5-methyl-1-beta-L-arabinofuranosyluracil ([18F]-L-FMAU) for PETUday Mukhopadhyay, Ashutosh Pal, Juri G Gelovani, et al.
Tetrahedron Letters|August 12, 2014
Asymmetric Synthesis of the C1-C6 Portion of the Psymberin Using an Evans Chiral AuxiliaryAshutosh Pal, Zhenghong Peng, Paul T Schuber, et al.
Bioorganic & Medicinal Chemistry|November 28, 2013
Curcumin glucuronides: assessing the proliferative activity against human cell linesAshutosh Pal, Bokyung Sung, Basvoju A Bhanu Prasad, et al.
Bioorganic & Medicinal Chemistry|November 1, 2011
Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myelomaZhenghong Peng, Ashutosh Pal, Dongmei Han, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2007
Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLTRyuichi Nishii, Andrei Y Volgin, Osama Mawlawi, et al.
3 Biotech|June 29, 2026
Laccase as a green biocatalyst for xenobiotic degradation: integrative insights from molecular docking and bibliometric analysisShivangi Chamoli, Ananta Gupta, Ashutosh Pal, et al.
Molecular Carcinogenesis|February 6, 2008
Interferon-inducible protein IFIXalpha inhibits cell invasion by upregulating the metastasis suppressor maspinHirohito Yamaguchi, Yi Ding, Jin-Fong Lee, et al.
Molecular Cancer Therapeutics|January 11, 2013
Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapyThiruvengadam Arumugam, Vijaya Ramachandran, Duoli Sun, et al.
Molecular Cancer Therapeutics|July 23, 2008
Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cellsDongwei Zhang, Ashutosh Pal, William G Bornmann, et al.
Pageof 3